RGNX logo

REGENXBIO (RGNX) EBITDA

Annual EBITDA

-$239.46 M
+$4.78 M+1.96%

December 31, 2023

Summary

Performance

1-Year Change

+1.96%

3-Year Change

-147.3%

5-Year Change

-321.52%

15-Year Change

-227.14%

RGNX EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

5.42%
RGNX annual EBITDA is higher than 5.42% of companies in Healthcare sector

High & Low

All-time High

$177.09 M
RGNX annual EBITDA is currently -235.22% below its historical high of $177.09 million

3-Year Low

-$244.24 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
RGNX previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 27, 2025
RGNX next annual earnings announcement is scheduled for Feb 27, 2025

OtherRGNXprofitabilitymetrics:

Annual Revenue

$90.24 M
RGNX annual revenue is $90.24 million

Annual Net Income

-$263.49 M
RGNX annual net profit is -$263.49 million

Annual EBIT

-$256.78 M
RGNX annual earnings before interest & taxes is -$256.78 million

Annual EPS

-$6.02
RGNX annual earnings per share is -$6.02

Quarterly EBITDA

-$54.82 M
-$6.33 M-13.05%

September 30, 2024

Summary

Performance

3-Month Change

-13.05%

1-Year Change

-13.05%

3-Year Change

-12.17%

5-Year Change

-61.08%

RGNX Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

7.38%
RGNX quarterly EBITDA is higher than 7.38% of companies in Healthcare sector

High & Low

All-time High

$316.53 M
RGNX quarterly EBITDA is currently -117.32% below its historical high of $316.53 million

3-Year Low

-$68.04 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
RGNX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 27, 2025
RGNX next earnings announcement is scheduled for Feb 27, 2025

OtherRGNXprofitabilitymetrics:

Quarterly Revenue

$24.20 M
RGNX quarterly revenue is $24.20 million

Quarterly Net Income

-$59.60 M
RGNX quarterly net profit is -$59.60 million

Quarterly EBIT

-$58.78 M
RGNX quarterly earnings before interest & taxes is -$58.78 million

Quarterly EPS

-$1.17
RGNX quarterly earnings per share is -$1.17

TTM EBITDA

-$217.82 M
+$1.06 M+0.48%

September 30, 2024

Summary

Performance

3-Month Change

+0.48%

1-Year Change

+0.48%

3-Year Change

-23.02%

5-Year Change

-141.13%

RGNX TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

6.88%
RGNX TTM EBITDA is higher than 6.88% of companies in Healthcare sector

High & Low

All-time High

$177.09 M
RGNX TTM EBITDA is currently -223.00% below its historical high of $177.09 million

3-Year Low

-$244.24 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
RGNX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 27, 2025
RGNX next earnings announcement is scheduled for Feb 27, 2025

OtherRGNXprofitabilitymetrics:

TTM Revenue

$84.33 M
RGNX TTM revenue is $84.33 million

TTM Net Income

-$238.81 M
RGNX TTM net profit is -$238.81 million

TTM EBIT

-$234.35 M
RGNX TTM earnings before interest & taxes is -$234.35 million

TTM EPS

-$5.02
RGNX TTM earnings per share is -$5.02

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$239.46 M
RGNX annual EBITDA is -$239.46 million

Annual Net Income

-$263.49 M
RGNX annual net profit is -$263.49 million

Annual Interest Expense

$6.86 M
RGNX annual interest expense is $6.86 million

Annual Income Tax

-$152.00 K
RGNX annual income tax is -$152.00 thousand

Annual D&A

$17.32 M
RGNX annual depreciation & amortization is $17.32 million

RGNX EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+2.0%-13.1%+0.5%
3 y3 years-147.3%-12.2%-23.0%
5 y5 years-321.5%-61.1%-141.1%

RGNX EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-235.2%+2.0%-117.3%+19.4%-223.0%+10.8%
5 y5-year-235.2%+2.0%-117.3%+19.4%-223.0%+10.8%
alltimeall time-235.2%+2.0%-117.3%+19.4%-223.0%+10.8%

REGENXBIO EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$54.82 M(+13.0%)
-$217.82 M(-0.5%)
Jun 2024
-
-$48.49 M(-15.2%)
-$218.88 M(-7.6%)
Mar 2024
-
-$57.18 M(-0.3%)
-$236.90 M(-1.1%)
Dec 2023
-$239.46 M(-2.0%)
-$57.34 M(+2.6%)
-$239.46 M(+2.5%)
Sep 2023
-
-$55.87 M(-16.0%)
-$233.66 M(-4.1%)
Jun 2023
-
-$66.51 M(+11.3%)
-$243.77 M(+3.3%)
Mar 2023
-
-$59.74 M(+15.9%)
-$235.94 M(-3.4%)
Dec 2022
-$244.24 M(-237.9%)
-$51.54 M(-21.9%)
-$244.24 M(-297.2%)
Sep 2022
-
-$65.98 M(+12.4%)
$123.83 M(-12.1%)
Jun 2022
-
-$58.68 M(-13.8%)
$140.94 M(-6.4%)
Mar 2022
-
-$68.04 M(-121.5%)
$150.55 M(-15.0%)
Dec 2021
$177.09 M(-282.9%)
$316.53 M(-747.7%)
$177.09 M(-200.0%)
Sep 2021
-
-$48.87 M(-0.4%)
-$177.07 M(+51.0%)
Jun 2021
-
-$49.07 M(+18.2%)
-$117.23 M(+16.9%)
Mar 2021
-
-$41.50 M(+10.3%)
-$100.29 M(+3.6%)
Dec 2020
-$96.83 M(+7.2%)
-$37.62 M(-443.1%)
-$96.83 M(+110.0%)
Sep 2020
-
$10.96 M(-134.1%)
-$46.10 M(-49.4%)
Jun 2020
-
-$32.13 M(-15.5%)
-$91.09 M(-3.2%)
Mar 2020
-
-$38.04 M(-390.2%)
-$94.09 M(+4.2%)
Dec 2019
-$90.34 M
$13.11 M(-138.5%)
-$90.34 M(+8.0%)
Sep 2019
-
-$34.03 M(-3.1%)
-$83.67 M(+17.1%)
DateAnnualQuarterlyTTM
Jun 2019
-
-$35.12 M(+2.4%)
-$71.42 M(+145.8%)
Mar 2019
-
-$34.29 M(-273.4%)
-$29.05 M(-126.9%)
Dec 2018
$108.10 M(-247.7%)
$19.78 M(-190.8%)
$108.10 M(+49.2%)
Sep 2018
-
-$21.78 M(-400.6%)
$72.45 M(-1.6%)
Jun 2018
-
$7.25 M(-93.0%)
$73.63 M(+41.5%)
Mar 2018
-
$102.86 M(-747.9%)
$52.03 M(-171.1%)
Dec 2017
-$73.20 M(+13.0%)
-$15.88 M(-22.9%)
-$73.20 M(-5.6%)
Sep 2017
-
-$20.60 M(+43.5%)
-$77.51 M(+2.8%)
Jun 2017
-
-$14.35 M(-35.8%)
-$75.42 M(-0.7%)
Mar 2017
-
-$22.37 M(+10.8%)
-$75.96 M(+17.2%)
Dec 2016
-$64.80 M(+185.3%)
-$20.19 M(+9.1%)
-$64.80 M(+30.3%)
Sep 2016
-
-$18.51 M(+24.2%)
-$49.75 M(+29.0%)
Jun 2016
-
-$14.90 M(+33.0%)
-$38.56 M(+28.8%)
Mar 2016
-
-$11.20 M(+118.0%)
-$29.94 M(+31.7%)
Dec 2015
-$22.71 M(+516.8%)
-$5.14 M(-29.8%)
-$22.72 M(+14.8%)
Sep 2015
-
-$7.32 M(+16.6%)
-$19.80 M(+39.6%)
Jun 2015
-
-$6.28 M(+57.2%)
-$14.18 M(+79.3%)
Mar 2015
-
-$3.99 M(+80.0%)
-$7.91 M(+101.9%)
Dec 2014
-$3.68 M(-22.9%)
-$2.22 M(+30.3%)
-$3.92 M(+130.3%)
Sep 2014
-
-$1.70 M
-$1.70 M
Dec 2013
-$4.78 M
-
-

FAQ

  • What is REGENXBIO annual EBITDA?
  • What is the all time high annual EBITDA for REGENXBIO?
  • What is REGENXBIO annual EBITDA year-on-year change?
  • What is REGENXBIO quarterly EBITDA?
  • What is the all time high quarterly EBITDA for REGENXBIO?
  • What is REGENXBIO quarterly EBITDA year-on-year change?
  • What is REGENXBIO TTM EBITDA?
  • What is the all time high TTM EBITDA for REGENXBIO?
  • What is REGENXBIO TTM EBITDA year-on-year change?

What is REGENXBIO annual EBITDA?

The current annual EBITDA of RGNX is -$239.46 M

What is the all time high annual EBITDA for REGENXBIO?

REGENXBIO all-time high annual EBITDA is $177.09 M

What is REGENXBIO annual EBITDA year-on-year change?

Over the past year, RGNX annual EBITDA has changed by +$4.78 M (+1.96%)

What is REGENXBIO quarterly EBITDA?

The current quarterly EBITDA of RGNX is -$54.82 M

What is the all time high quarterly EBITDA for REGENXBIO?

REGENXBIO all-time high quarterly EBITDA is $316.53 M

What is REGENXBIO quarterly EBITDA year-on-year change?

Over the past year, RGNX quarterly EBITDA has changed by -$6.33 M (-13.05%)

What is REGENXBIO TTM EBITDA?

The current TTM EBITDA of RGNX is -$217.82 M

What is the all time high TTM EBITDA for REGENXBIO?

REGENXBIO all-time high TTM EBITDA is $177.09 M

What is REGENXBIO TTM EBITDA year-on-year change?

Over the past year, RGNX TTM EBITDA has changed by +$1.06 M (+0.48%)